The Vanderbilt Ingram Cancer Center (Neil Brake/Vanderbilt)

Cancer research and education agreement announced between Baptist Memorial Health Care and Vanderbilt University

Myelosuppression unit set to move to new CCT space

Proteins help flip tumor’s invasive switch

Vanderbilt investigators have identified how two key components of cancer’s invasive “switch” — the series of signaling events that turn on a tumor cell’s invasive behavior — work together.

Target acquired for aggressive tumor

New therapeutic target for angiosarcoma – an aggressive, highly fatal tumor of the blood vessels – identified.

HER2 may impact lung cancer therapy

A protein associated with aggressive breast cancers may also influence resistance of lung cancer to targeted therapies.

Photo: Signing up

1 13 14 15 16 17 22